Q-omics provides the consensus-scored RPL32P35 profile across patient tissues and cancer cell-line models. RPL32P35 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in CESC. Additionally, RPL32P35 RNA expression shows 8,504 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight CESC, and BRCA as cancer lineages where RPL32P35 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.